Acetylsalicylic acid Completed Phase N/A Trials for Type 2 Diabetes Mellitus Basic Science

Indications	Status	Purpose	Phase
DBCOND0029752 (Type 2 Diabetes Mellitus)	Completed	Basic Science	Not Available

clinicaltrials.gov Identifier	Title	Drugs
NCT01740921	GLP-1 and Microvascular Function in Type 2 Diabetes	Liraglutide (DB06655) Acetylsalicylic acid (DB00945)
NCT00898950	Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes	Salicylic acid (DB00936) Acetylsalicylic acid (DB00945)